drugset / Trial / NCT02625714
Safety/Tolerability and Pharmacokinetic Study of SID142
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open-label, oral multiple dosing, two-part, two-way crossover clinical trial to evaluate the safety/tolerability and pharmacokinetic profiles of SID142 in healthy volunteers
Timeline
- Start
- 2015-06
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 100 mg | Oral |
| Subject | Cilostazol | Small molecule | 200 mg | Oral |
| Subject | ginko biloba leaf extract | Unknown | 80 mg | Oral |
| Subject | ginko biloba leaf extract | Unknown | 160 mg | Oral |